Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.
Conclusions: The role of FDG-PET/CT surveillance is limited, and differs according to the lymphoma subtype. FDG-PET/CT may be useful in detecting early relapse in patients with aggressive T-cell NHL, including those with low/low-intermediate risk secondary IPI; as already known, FDG-PET/CT has no role in aggressive B-cell NHL. Repeat biopsy should be performed to discriminate relapse or transformation from false positive findings in patients with positive surveillance FDG-PET/CT results.
PMID: 32550718 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Kim YR, Kim SJ, Cheong JW, Kim Y, Jang JE, Cho H, Chung H, Min YH, Yang WI, Cho A, Kim JS Tags: Korean J Intern Med Source Type: research
More News: Cancer & Oncology | CT Scan | Hodgkin's Disease | Internal Medicine | Lymphoma | Non-Hodgkin's Lymphoma | PET Scan